With some tweaks, CAR-T cancer therapy could be made safer — and more widely available — study suggests
With some tweaks, CAR-T #cancer therapy could be made safer — and more widely available — a new study suggests.
A novel approach to CAR-T cancer therapy promises to upend what has become a truism in medicine: that the treatment’s dramatic effect on tumors comes with serious risks to patient safety.
In a small clinical trial, patients treated with a slightly modified version of an approved CAR-T saw benefits on par with previous studies but with none of the hallmark side effects that can leave some patients hospitalized and in need of costly extra treatments.
The study enrolled just 25 patients in China, according to data published
